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To evaluate the biomarkers of sexual function, we investigated the relationship between
questionnaire responses and biological hormones such as testosterone (T) and cortisol (F) in serum
and saliva. The study population included 105 men aged 30–72 years (mean: 49±4.5, median: 49).
Levels of all serum hormones (Total-T, Free-T, Bioavailable-T, Total-F and Bioavailable-F) and
salivary hormones (Saliva-T and Saliva-F) were measured directly by liquid chromatography/
tandem mass spectrometry. The International Index of Erectile Function (IIEF) was used as a
questionnaire to evaluate sexual dysfunction. Free-T and Bioavailable-T showed significant inverse
correlations with age (Po0.01). In the group not taking antidepressants, the levels of Bioavailable-F
and Saliva-F showed significant inverse correlations with a portion of the IIEF score (Po0.05).
However, reductions in Bioavailable-T and Saliva-T showed no association with the IIEF score.
In the group taking antidepressants, these hormone levels showed no correlation with IIEF.
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Introduction
Male sexual hormones such as androgens are
generally considered to be associated with sexual
function. Among the androgens, testosterone (T)
is a useful marker that is frequently used to eva-
luate male hypogonadism. Androgen production
decreases with aging, and decreased testosterone
is thought to induce late-onset hypogonadism, one
of the most common symptoms of which is erectile
dysfunction (ED).
1 Late-onset hypogonadism is
defined as a biochemical syndrome associated with
advancing age and characterized by a deficiency in
serum androgen levels with or without decreased
genomic sensitivity to androgens. It may result in
significant alterations in the quality of life and
adversely affect the function of multiple organ
systems.
2 In Japan, measurement of free testosterone
is recommended to diagnose late-onset hypogona-
dism.
Serum total testosterone (Total-T) consists of
testosterone that binds strongly to sex hormone-
binding globulin (SHBG), the testosterone that
loosely binds to albumin and free testosterone
(Free-T). The latter two are designated collectively
as bioavailable-T (Bio-T), and its measurement is
considered to be an index of androgen activity.
3
In addition, the T of saliva (Sa-T) is regarded as
free testosterone, and its measurement is thought to
reflect blood Free-T and Bio-T.
4 It has been reported
that Total-T does not vary, but Free-T decreases
gradually with aging.
5
Cortisol (F), which is an adrenal cortical hormone,
does not show changes in level with aging, but is
increased by stress.
6 Cortisol remains constant after
increasing during the period of sexual maturation at
the same time as T. Cortisol is known to raise blood
pressure and blood sugar levels as well as cause
sterility and immune dysfunction. When we feel
stress, fear or tension, sympathetic nervous activity
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activity, and the penis is contracted. Blood cortisol
levels are known to increase in the hypothalamic–
pituitary–adrenocortical system at the same time as
that in which blood norepinephrine levels increase
in the sympathetic nervous–adrenal medullary
system when sympathetic nervous activity is domi-
nant. Thus, ED may occur when cortisol levels are
high. Although the cortisol level may reflect sexual
function, there have been no earlier investigations of
the relationships between these two parameters.
Similar to Bio-T, bioavailable cortisol (Bio-F) is an
active form that does not bind to globulin, and saliva
cortisol (Sa-F) is secreted in the saliva as the free
type.
7 Here, we developed methods to measure
testosterone and cortisol levels in the blood and
saliva by liquid chromatography/tandem mass spec-
trometry (LC/MS-MS).
8 We measured various hor-
mones directly using this method and investigated
the correlations of these hormone levels and sexual
function on the basis of questionnaire responses
from 105 patients.
Materials and methods
Patients
The study population included 103 men aged 32–72
years (mean: 49±4.5, median: 49). All patients
visited our hospital for treatment of urological
symptoms, including late-onset hypogonadism,
with or without ED. Thirteen patients were taking
antihypertensive agents and two patients were
taking antidiabetic drugs. None of the patients were
taking hormone medication (supplementation or
deprivation) or phosphodiesterase type 5 (PDE5)
inhibitors. All patients gave full informed consent to
participate in this study. Saliva and serum samples
were collected in the morning (between 0900 and
1100 hours). In addition, we investigated their
sexual function and examined whether the patients
had taken any psychotropic drugs. Each patient also
completed validated questionnaires exploring anxi-
ety and depression (Hospital Anxiety and Depres-
sion Scale [HAD scale]). This study was approved by
the Internal Review Board of Kanazawa University,
and was supported by a medical research fund from
Kanazawa University Hospital (Kanazawa, Japan).
LC-MS/MS
Levels of all serum hormones (Total-T, Free-T, Bio-T,
Total-F and Bio-F) and salivary hormones (Sa-T and
Sa-F) were measured directly by LC/MS-MS. LC/
MS-MS is effective for determining fixed quantities
of very small amounts of material in biological
samples.
9 The LC/MS-MS apparatus used was an
API4000 (Applied Biosystems, Kanazawa, Ishikawa,
Japan) mass spectrometer and an HP1100 (Hewlett-
Packard, Kanazawa, Ishikawa, Japan) liquid chro-
matograph. Bioavailable T (Bio-T) and F (Bio-F)
were determined after separation of the SHBG-
bound steroid.
Conventionally, Bio-T was calculated on the basis
of albumin, SHBG and Total-T, using the method
proposed by the International Society for the Study
of the Aging Male. However, Bio-T and Bio-F were
measured directly as levels of non-SHBG-bound
T and F using LC/MS-MS in our study.
Definition of erectile function
To evaluate sexual dysfunction, the International
Index of Erectile Function (IIEF) was used as
a questionnaire study.
10 IIEF is divided into
five domains (erectile function, orgasmic function,
sexual desire, intercourse satisfaction and overall
Table 1 Correlation coefficient between the age and hormonal profile
Testosterone Cortisol
Total Free Bio Saliva Total Bio Saliva
Age 0.01 –0.35*** –0.30** –0.19* 0.07 0.10 0.17
Testosterone
Total — 0.52**** 0.65**** 0.47**** 0.02 0.06 0.08
Free — — 0.77**** 0.67**** 0.18* 0.15 0.16
Bio — — — 0.71**** 0.05 0.14 0.08
Saliva — — — — 0.06 0.13 0.12
Cortisol
Total — — — — — 0.91**** 0.80****
Bio — — — — — — 0.79****
Saliva — — — — — — —
n¼103.
*Po0.10, **Po0.01, ***Po0.001, ****Po0.0001.
Speaman’s rank test.
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neously.
11 Men who did not complete the ques-
tionnaire were excluded from statistical analysis.
Statistical analysis
Data from completed questionnaires were input into
a Microsoft Excel spreadsheet. All analyses were
performed with a SAS package (version 8.1) and
differences were considered significant at Po0.05.
The hormonal values were subjected to logarithmic
transformation and controlled for age. Thereafter, we
examined correlations between IIEF responses and
hormonal levels. Spearman’s rank test was used to
test the correlations between age and hormonal
profile, IIEF score and hormonal profile.
Results
The relationships of testosterone and cortisol to age
are shown in Table 1. Free-T and Bio-T showed
significant inverse correlations with age (Po0.01).
Sa-T showed a tendency toward a negative correla-
tion, but the relation was not significant. Cortisol
did not have a meaningful correlation with age
(Figure 1). In addition, the levels of each type of
testosterone (Total-T, Free-T, Bio-T and Sa-T)
showed very strong correlations to the other forms
of testosterone and there were also correlations
among cortisol levels (Total-F, Bio-F and Sa-F).
Table 2 shows the baseline characteristics and the
levels of each hormone in men who did and did not
take psychotropic drugs. Sixty-four of the 103
patients included in the investigation (62%) took
psychotropic drugs. The HAD scale was signi-
ficantly high in the group taking psychotropic drugs.
It was suggested that populations of men who took
psychotropic drugs suffered from anxiety and
depression. With regard to different types of psycho-
tropic drugs, 15 patients took only selective seroto-
nin reuptake inhibitors (SSRI), 14 took serotonin
and norepinephrine reuptake inhibitors (SNRI), 9
took tricyclic antidepressants, 10 took minor tran-
quilizers and 16 patients took antidepressants and
minor tranquilizers. Men who did not take psycho-
tropic drugs showed significantly lower Total-T
levels. There were no significant differences in
levels of hormones other than those of Total-T.
When we examined the correlation between
hormonal level and IIEF response, the hormonal
levels were controlled for age, as it is well known
that testosterone shows a significant inverse correla-
tion with age. Table 3 shows the correlation
coefficients for each domain of IIEF (erectile func-
tion, orgasmic function, sexual desire, intercourse
satisfaction and overall satisfaction), IIEF5 and total
score of IIEF, with various hormones in men who
did not take psychotropic drugs. Bio-F showed
negative correlations with erectile function, sexual
desire, IIEF5 and total IIEF score (Po0.05). In
addition, Sa-F showed negative correlations with
intercourse satisfaction and total IIEF score
(Po0.05). However, testosterone did not show a
meaningful correlation with any of the IIEF domains
(Figure 2).
There were no significant correlations between
the various hormones and IIEF in this group who
took psychotropic drugs.
Figure 1 (a) Free testosterone showed significant inverse
correlations with age (n¼103, R¼ 0.35, Po0.001). (b) On the
other hand, bioavailable cortisol did not have a meaningful
correlation with age (n¼103, R¼0.10, P¼0.10).
The relationship of serum and salivary cortisol levels
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It has been suggested that androgen insufficiency
disrupts cellular signaling pathways and produces
pathological alterations in penile tissues, leading to
ED.
12 Although there is evidence suggesting that
testosterone plays an important role in erectile
function, testosterone levels below the normal lower
limit may still be sufficient to retain a normal
erectile function in most men.
13,14 The weak
relationship between low T and ED is well known
and supported by the results of both human and
animal studies.
15 A lack of association between T
and IIEF-5 has been documented in a large con-
secutive series of almost 1000 elderly individuals
with or without ED.
16 In ED patients, hypogonadism
is often associated with reduced sexual desire and
nocturnal penile erections, whereas association
with sex-induced erection is less evident. This is
because T regulates not only cyclic guanosine
monophosphate formation through nitric oxide
synthase stimulation but also its catabolism through
PDE5 activity. Androgens positively regulate PDE5,
thus providing a possible explanation for the highest
levels of this enzyme in the male genital tract.
17
The androgen-dependent PDE5 expression could
explain the reduced effectiveness of PDE5 inhibitors
in the treatment of ED in hypogonadal patients. As
T positively regulates both the initiation (nitric
oxide synthase) and the end (PDE5) of the erectile
process, its net effect on erection is modest. Hence,
erections are still possible under hypogonadal
conditions in which decreased cyclic guanosine
monophosphate formation because of impaired NO
production is most likely counterbalanced by regu-
lated PDE5 activity and cyclic guanosine monophos-
phate hydrolysis. The main physiological action of
T is therefore to ensure the timely adjustment of the
erectile process as a function of sexual desire,
therefore finalizing erection associated with sex. A
trophic effect of Ton the penile architecture has also
been shown in different animal species.
18 For all of
the above reasons, treating hypogonadism restores
impaired penile erections in experimental animal
models, as well as in a clinical setting. Conversely, T
administration to otherwise eugonadal individuals
is rather ineffective. There have been many reports
that sexual function is improved by androgen
replacement therapy.
19–21 All the above considera-
tions explain the well-known weak correlation
between ED and T. In this study, there was no
correlation between testosterone and IIEF responses.
That is, testosterone is not an appropriate biomarker
for an evaluation of sexual function.
Table 2 Baseline characteristics and hormonal level (the use of
antidepressants vs the non-use of antidepressants)
Number of patients (%)
Not take
(n¼39)
Take
(n¼64)
P-value
High blood pressure 6 (15.4) 8 (12.5) 0.67
Diabetes mellitus 2 (5.1) 5 (7.8) 0.59
Cardiac treatment 2 (5.1) 2 (3.1) 0.61
Benign prostatic
hyperplasia
3 (7.6) 5 (7.8) 0.98
Mean±s.d.
Age 48.38±10.11 49.76±9.78 0.52
BMI (kg/m
2) 22.41±2.78 23.77±2.64 0.44
HAD scale
Depression 8.13±4.16 11.23±4.2 o0.01
Anxiety 7.68±3.61 9.45±4.29 0.02
Total score 15.81±6.8 20.55±7.5 o0.01
Testosterone
Total (ngml
 1) 4.77±1.60 3.86±2.44 0.03
Free (pgml
 1) 10.20±2.85 9.27±3.43 0.16
Bio (pgml
 1) 965.73±359.81 841.45±383.46 0.11
Saliva (pgml
 1) 55.70±23.57 55.91±29.81 0.97
Cortisol
Total (ngml
 1) 108.42±35.05 100.89±42.34 0.35
Bio (ngml
 1) 20.58±10.78 19.41±9.95 0.58
Saliva (ngml
 1) 2.36±1.57 1.91±1.26 0.13
Table 3 Correlation coefficient between the IIEF score and hormonal profile (The group who did not take psychotropic drugs)
Testosterone Cortisol
Total Free Bio Saliva Total Bio Saliva
Erectile function –0.26 –0.07 –0.01 –0.13 –0.28 –0.39** –0.30
Orgasmic function –0.10 –0.06 0.05 0.04 –0.20 –0.27 –0.19
Sexual desire –0.08 –0.05 –0.02 –0.20 –0.30 –0.44** –0.35*
Intercourse satisfaction –0.23 –0.12 0.00 –0.11 –0.26 –0.33* –0.37**
Overall satisfaction –0.07 –0.33* –0.16 –0.17 –0.19 –0.29 –0.32*
Total score of IIEF –0.24 –0.12 –0.01 –0.13 –0.31* –0.43** –0.37**
IIEF5 –0.25 –0.08 0.00 –0.15 –0.29 –0.38** –0.30*
*Po0.10, **Po0.05.
Speaman’s rank test.
n¼32.
The relationship of serum and salivary cortisol levels
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correlations with some domains of IIEF in this
study. In a rat model of adrenal insufficiency, it was
shown earlier that the rat adrenal gland contributes
to the maintenance of the erectile mechanism and
may affect the neuronal nitric oxide synthase
content in the penis.
22 In a human study, on the
other hand, there were no differences in cortisol
levels between individuals with and without ED.
23
These studies did not include detailed differential
counts of cortisol. However, in our study, Bio-F and
Sa-F (not Total-F) showed negative correlations with
the IIEF score. This suggested that Bio-F and Sa-F,
which are active forms of cortisol, likely decrease
sexual function. One reason why ED occurred in
patients with high levels of cortisol is because
cortisol is increased by stress. It is known that the
blood cortisol level increases at the same time as
the blood norepinephrine level when sympathetic
nervous activity is dominant. Sympathetic nervous
activity has a restraining effect on erection, and
sexual function is thought to be reduced under
stress.
24,25 Our results indicate that increases in
plasma and salivary cortisol may play causative
roles in ED induced by social stress.
In studies of stress, cortisol and norepinephrine
have been overused as standard stress markers.
Cortisol level is an index of the endocrine response
to stress and shows comparatively high normal
values in blood (100–150ngml
 1). We can analyze
cortisol from saliva if we use a high sensitivity
analytical procedure such as ELISA or LC-MS/MS.
26
Measuring cortisol in saliva may become a useful
index for evaluating the sexual function non-
invasively. In addition, saliva-based measurement
methods have attracted attention for measuring
amylase in saliva as a marker of the sympathetic
nervous system response to stress.
27 Further studies
in this field are needed.
In the men who took antidepressants in this study,
there were no significant correlations between hor-
mone values and IIEF. Neither testosterone nor
cortisol values played an important role in erectile
function in the group taking antidepressants. This
was thought to be because ED and ejaculation
disorder are induced by the actions of antidepressant
medication. Furthermore, psychiatric disorder in
itself may be a cause of ED.
28 Patients with depression
may have elevated cortisol levels.
29 In addition, this
type of drug could result in an increase in the
prolactin level determining the reduction of T.
30
Therefore, we could not obtain meaningful data from
the patients taking psychotropic drugs.
Conclusions
The active forms of cortisol (Bio-F and Sa-F) showed
negative correlations with sexual function in men
who did not take psychotropic drugs, although there
was no such correlation for testosterone. ED is
thought to occur in patients with high levels of
cortisol because of the relations between cortisol
and stress. Cortisol may thus become a useful index
for the evaluation of sexual function.
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